GSK CEO says team reorg could be in the cards pending upcoming Phase 3 readouts

Luke Miels, GSK CEO April 29, 2026 07:22 AM EDTUpdated 08:42 AM PeoplePharma GSK CEO says team re­org could be in the cards pend­ing up­com­ing Phase 3 read­outs Ayisha Sharma News Reporter GSK is ex­pect­ing sev­er­al key late-stage read­outs this year and, if they do not suc­ceed, the com­pa­ny could change its team struc­ture, CEO Luke Miels … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER